Skip to NavigationSkip to content

News

In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary endpoints in a Phase 3 trial,...
MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in the hepatitis C space, citing a crowded...
Super malaria outbreak, 19 patients deaths in Intercept's trial, a new triple-threat HIV treatment and EMA warnings of drug delays following its...
Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. The market reacted to the news...
The FDA has announced that it plans to mandate manufacturers of such drugs to fund voluntary training for healthcare professionals who prescribe...
Eli Lilly has received an important approval for its breast cancer treatment, Verzenio, but analysts doubt how much impact it will be able to make in...
After a financial deal was agreed with Amgen, it looks like AbbVie's Humira should have the immediate biosimilar threat removed from its path running...
A new study conducted by researchers from the European Centre for Disease Prevention and Control found that new cases had increased by 2% in those...
Roche has announced that its drug Ocrevus has received marketing approval in Switzerland for the treatment of active relapsing forms of multiple...
Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the blockbuster sales pinned to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches